Showing 1 - 11 results of 11 for search 'Yu. M. Gomon', query time: 0.10s Refine Results
  1. 1
    Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study

    Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study by A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Factors associated with adverse outcome among hospitalized patients with moderate to severe COVID-19

    Factors associated with adverse outcome among hospitalized patients with moderate to severe COVID-19 by S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, E. V. Verbitskaya, T. I. Galimov

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    A systematic review of real-world clinical practice data in COVID-19: non-interventional studies

    A systematic review of real-world clinical practice data in COVID-19: non-interventional studies by S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Socio-economic burden of COVID-19 in the Russian Federation

    Socio-economic burden of COVID-19 in the Russian Federation by A. S. Kolbin, D. Yu. Belousov, Yu. M. Gomon, Yu. E. Balykina, I. G. Ivanov

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies

    The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies by A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Cystic fibrosis as a social-economic burden

    Cystic fibrosis as a social-economic burden by A. S. Kolbin, Yu. M. Gomon, O. I. Karpov, Yu. E. Balykina, M. A. Proskurin

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Approaches to Assessing the Safety of Medicines during the COVID-19 Pandemic Using the Example of Azithromycin

    Approaches to Assessing the Safety of Medicines during the COVID-19 Pandemic Using the Example of Azithromycin by Yu. M. Gomon, A. R. Kasimova, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov, S. O. Mazurenko

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Socioeconomic and global burden of COVID-19

    Socioeconomic and global burden of COVID-19 by A. S. Kolbin, Yu. M. Gomon, Yu. E. Balykina, D. Yu. Belousov, V. V. Strizheletskiy, I. G. Ivanov

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    ECONOMIC ASSESSMENT OF THE EFFECTIVENESS AND SAFETY OF THE COMMONLY PRACTICED PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS (BASED ON AN EARLIER EPIDEMIOLOGICAL SURVEY OF MULTIDISCIPLINARY HOSPITALS)

    ECONOMIC ASSESSMENT OF THE EFFECTIVENESS AND SAFETY OF THE COMMONLY PRACTICED PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS (BASED ON AN EARLIER EPIDEMIOLOGICAL SURVEY OF MULTIDISCIPLINARY... by Yu. M. Gomon, A. S. Kolbin, S. V. Sidorenko, A. M. Kuzhel', A. V. Repina, Yu. V. Lobzin, Yu. E. Balykina

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    Modeling microbial drug-resistance: from mathematics to pharmacoeconomics

    Modeling microbial drug-resistance: from mathematics to pharmacoeconomics by Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  11. 11
    Efficiency of Levilimab in patients with moderate and severe COVID-19

    Efficiency of Levilimab in patients with moderate and severe COVID-19 by Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A.  S. Kolbin, M. V. Livshits, T.  A. Usmanova, A. M. Fakhrutdinova, Yu. S.  Konstantinova, A. P. Gubanov

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: